Quantitative Estimation of Sorafenib Tosylate Its Pure Form and in Its Tablet Formulation by RP-HPLC Method

Table 2

Recovery study.

Sample	Label claim (mg/tablet)	Amount of drug; added (𝜇g/mL)	Amount of drug; recovered (𝜇g/mL)	Percentage recovery ± SD^a
Sorafenib tablets	200	32	32.08	100.23±0.070
		40	39.92	99.81±0.236
		48	47.98	99.95±0.058

^aMean of six determinations.